Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us

Breadcrumb

  1. Emmes Group

Management of Metabolic Effects Associated with Anticancer Agents Targeting the PI3K-Akt-mTOR Pathway

Go back to Resources

Management of Metabolic Effects Associated with Anticancer Agents Targeting the PI3K-Akt-mTOR Pathway

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Joint Modeling of Longitudinal and Survival Data with Missing and Left-Censored Time-Varying Covariates

Go back to Resources

Joint Modeling of Longitudinal and Survival Data with Missing and Left-Censored Time-Varying Covariates

Authors:

Secondary:

Location:

Go back to Resources

Islet Cell Transplantation in Type 1 Diabetes: An Analysis of Clinical Outcomes in Data from the Collaborative Islet Transplant Registry (CITR)

Go back to Resources

Islet Cell Transplantation in Type 1 Diabetes: An Analysis of Clinical Outcomes in Data from the Collaborative Islet Transplant Registry (CITR)

Authors:

Secondary:

Location:

URL:

Keywords:

Abstract:

Go back to Resources

Iron Status in Children with Autism Spectrum Disorder

Go back to Resources

Iron Status in Children with Autism Spectrum Disorder

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Information-Seeking Behaviors of Dental Practitioners in Three Practice-Based Research Networks

Go back to Resources

Information-Seeking Behaviors of Dental Practitioners in Three Practice-Based Research Networks

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Implementation of a Drug Management Utility in a Multi-Site, Randomized, Double-Blinded Study

Go back to Resources

Implementation of a Drug Management Utility in a Multi-Site, Randomized, Double-Blinded Study

Authors:

Secondary:

Location:

URL:

Go back to Resources

First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Adenovirus Serotype 26 HIV-1 Env Vaccine (IPCAVD 001)

Go back to Resources

First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Adenovirus Serotype 26 HIV-1 Env Vaccine (IPCAVD 001)

Authors:

Secondary:

Volume:

Pagination:

URL:

Abstract:

Go back to Resources

Factors Influencing Adherence Behavior for Daily and Intermittent Regimens of Pre-Exposure Prophylaxis (PrEP) Among Men Who Have Sex With Men (MSM) in Kenya

Go back to Resources

Factors Influencing Adherence Behavior for Daily and Intermittent Regimens of Pre-Exposure Prophylaxis (PrEP) Among Men Who Have Sex With Men (MSM) in Kenya

Authors:

Secondary:

Location:

URL:

Go back to Resources

Exception from Informed Consent (EFIC): Experiences from a Randomized Trial in Pediatric Emergency Patients

Go back to Resources

Exception from Informed Consent (EFIC): Experiences from a Randomized Trial in Pediatric Emergency Patients

Authors:

Secondary:

Location:

URL:

Go back to Resources

Estimating Death Rates In Substance Use Disorder

Go back to Resources

Estimating Death Rates In Substance Use Disorder

Authors:

Secondary:

Location:

URL:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 199
  • Page 200
  • Page 201
  • Page 202
  • Current page 203
  • Page 204
  • Page 205
  • Page 206
  • Page 207
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us
linkedin X

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions
  • ISO Certification